cp wire

CP Wire Articles

Bristol-Myers Squibb and Vedanta Biosciences to Evaluate Opdivo and VE800 in Patients with Advanced or Metastatic Cancers
  • VE800, is based on work showing in preclinical models that certain gut-dwelling bacterial strains potentiate cytotoxic CD8+ T cells and enhance infiltration into tumors
  • Bristol-Myers... read more
Mon, 12/10/18 - 10:57 pm
Microbiome Report for Week Ending 12/1/18


Evelo Biosciences Announces First Dosing in Phase... read more

Sat, 12/8/18 - 01:59 pm
Biological Dynamics Selected as Winner of CONNECT’s 2018 Most Innovative New Product Award

Biological Dynamics announced on 12/7/18 that its OmniVerita system has been selected as the winner of CONNECT’s Most Innovative New Product Award in the Life Science Products, Clinical Stage... read more

Fri, 12/7/18 - 10:36 am
Kallyope Receives $21 Million in Series B Financing to Target the Gut-Brain Axis


Kallyope Inc., a leading biotechnology company focused on identifying therapeutic opportunities involving the gut-brain axis, today announced a $21 million expansion of its previously... read more

Wed, 12/5/18 - 02:44 pm
Clovis Oncology Prevails in European Patent Proceedings Related to Rubraca
  • Ruling will confirm European regulatory exclusivity for Rubraca until at least 2028
  • Clovis also recently received a patent for using Rubraca in high doses to treat cancer in the US... read more
Tue, 12/4/18 - 09:13 am

Pages